Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Schembl18763323
2. Zinc77301567
3. Akos025311217
4. Ac-24197
5. As-11034
6. 696k768
7. (2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-((1s,2r,3r,4s,6r)-4,6-diamino-3-((2s,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)-2-hydroxycyclohexyloxy)tetrahydro-2h-pyran-3,4-diol
| Molecular Weight | 483.5 g/mol |
|---|---|
| Molecular Formula | C18H37N5O10 |
| XLogP3 | -7.2 |
| Hydrogen Bond Donor Count | 11 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 6 |
| Exact Mass | 483.25404239 g/mol |
| Monoisotopic Mass | 483.25404239 g/mol |
| Topological Polar Surface Area | 288 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 639 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 15 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
Global Sales Information
ABOUT THIS PAGE
74
PharmaCompass offers a list of Bekanamycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bekanamycin manufacturer or Bekanamycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bekanamycin manufacturer or Bekanamycin supplier.
PharmaCompass also assists you with knowing the Bekanamycin API Price utilized in the formulation of products. Bekanamycin API Price is not always fixed or binding as the Bekanamycin Price is obtained through a variety of data sources. The Bekanamycin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A bekanamycin sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of bekanamycin sulfate, including repackagers and relabelers. The FDA regulates bekanamycin sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. bekanamycin sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A bekanamycin sulfate supplier is an individual or a company that provides bekanamycin sulfate active pharmaceutical ingredient (API) or bekanamycin sulfate finished formulations upon request. The bekanamycin sulfate suppliers may include bekanamycin sulfate API manufacturers, exporters, distributors and traders.
bekanamycin sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of bekanamycin sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right bekanamycin sulfate GMP manufacturer or bekanamycin sulfate GMP API supplier for your needs.
A bekanamycin sulfate CoA (Certificate of Analysis) is a formal document that attests to bekanamycin sulfate's compliance with bekanamycin sulfate specifications and serves as a tool for batch-level quality control.
bekanamycin sulfate CoA mostly includes findings from lab analyses of a specific batch. For each bekanamycin sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
bekanamycin sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (bekanamycin sulfate EP), bekanamycin sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (bekanamycin sulfate USP).
